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O11. Oral Session: Services and Other Interventions

King's College London
Background: We developed a smartphone-based personalised technology to monitor symptoms in real time and showed good acceptability, reliability and validity for active remote monitoring of symptoms in previous published studies (www.clintouch.com). We report a randomised trial testing its efficacy in improving psychotic symptom control, and its potential as an early warning system for relapse when embedded into the ICT systems of mental health provider organisations, and as a tool for identifying new phenotypes for precision medicine. Methods: Participants with SMI receive a semi-random beep 2-4 times per day on their smartphone app and answer 14 key symptom rating items using a touchscreen slider. Responses are uploaded wirelessly in real time to a central server and build into a graphical readout on the handset, allowing active symptom monitoring and attempts at self-management. We built this into an end-to-end system in two NHS Hospital Trusts (Manchester and South London) to stream data into electronic care records and enable detection by the clinical team of early signs of relapse in people with SMI when key symptoms exceeded a personalised severity threshold. We conducted an open randomised controlled trial of this active symptom monitoring (ASM) using the smartphone app compared to usual management with the aim of assessing: (i) acceptability of continuous monitoring over 3 months; (ii) impact of active self-monitoring on PANSS positive symptoms and Empowerment Rating Scale score assessed at 6 and 12 weeks; (iii) efficiency of detecting early warning signs of relapse. Eligible participants with a DSM5 diagnosis of schizophrenia and related disorders and a history of relapse within the previous two years were included from an early intervention team (early psychosis group) and a community team (chronic psychosis group). Results: Of 181 eligible, 81 were randomised to either active symptom monitoring or management as usual. 90% stayed in the trial for 12 weeks. Of the 38 in the ASM arm who completed 12-week follow up, adherence defined as responding to >33% of alerts was 84%, >50% of alerts was 60%. At 12 weeks, ASM compared to usual management was associated with no difference on empowerment scale. PANSS positive subscale score showed a significant mean reduction in the ASM group over 12 weeks in the early psychosis group (n= 22, planned ANCOVA p<0.02), but no effect in the chronic psychosis group (n=19). Early warning sign alerts generated by the system occurred in 92% of cases and blind comparison with electronic case record data suggested good sensitivity and lower specificity, but with clear indications of how to adjust the gain of the system to improve future eventdetection efficiency. Multivariate analyses pointed to the ability of the system to identify clinical subtypes. Discussion: The active smartphone monitoring system is feasible and acceptable over three months in people with schizophrenia and related disorders. It was associated with psychotic symptom improvement in recent onset participants, supporting the notion of improved self-management. When built into clinical management workflows to enable personalised alerts of symptom deterioration, it was shown to have potential use in promoting earlier intervention for relapse. Background: The cooperative and dynamic relationship between patients and therapist known as Working Alliance, has in two meta-analysis shown to be an important factor for positive outcome in psychotherapy regardless the modality of therapy. Studies investigating the association between working alliance and outcome conducted in cohorts of patients with mental illness treated in a case manager setting has reported an association between a strong working alliance and reduced symptom severity, better social function, adherence to psycho-social treatment.
O11.2. CHANGES IN PSYCHOPATHOLOGY PREDICT CHANGES IN WORKING ALLIANCE IN FIRST EPISODE PSYCHOSIS
For this study, we used data from a trial testing the effect of five years of specialized early intervention (SEI) compared to two years of SEI for patients diagnosed with first episode of schizophrenia spectrum disorder. We aimed to study the effect of the intervention on the working alliance and the change in working alliance as a dynamic factor in the two treatment conditions from baseline to follow-up. When extending specialized early intervention from two to five years' vs transferring to treatment as usual, we hypothesized a change in working alliance and psychopathology favoring the patient in the extended SEI group. Methods: Participants were recruited from SEI teams (OPUS) in Denmark. All newly diagnosed within the schizophrenia spectrum (ICD-10, F2), age between 18 and 35. Participants were included 1 ½ year after initiation of SEI treatment (baseline) and followed up 5 years after initiation of treatment. At both assessments participants were examined with a comprehensive assessment battery including working alliance, psychopathology, social function, cognitive function, adherence to medication and client satisfaction. Assessors were blind to treatment allocation. The primary outcome, working alliance inventory (WAI), was assessed by self-assessment. A change score was calculated by subtracting the baseline score from the follow-up score. Multivariable linear regression analyses were conducted, corrected for the baseline value of the independent and dependent variable. Results: Of the 289 participants who attended the follow-up interview 258 (89%) had completed the WAI at baseline and follow-up. Participants who were randomized to prolonged SEI had a stable WA from baseline to follow-up, while participants who were randomized to TAU had a mean drop in WA over the same period. Change in WA was associated with change in negative-, psychotic-, and disorganized symptoms dimension, and social function in the extended OPUS group. In the TAU group, we found that change in WA were negatively associated with change in cognitive function measured with BACS. In both groups, there were an association between the change in WA and change in client satisfaction. 
One in five patients with a psychotic disorder has a persistent low subjective well-being over three years. This group has a poorer prognosis for social functioning. This presentation reports on the first longitudinal study evaluating whether neuroticism and extraversion influence subjective well-being (SWB) in patients with a schizophrenia spectrum disorder. SWB is generally defined as 'the subjective experience, as constituting aspects of mental or physical state, which patients report regardless of etiological attributions'. It is an independent determinant for recovery in patients with a psychotic disorder. Two cross-sectional studies on quality of life in schizophrenia suggest that personality traits are associated with the way patients value life. If personality traits predict the trajectories of subjective well-being, our results would provide a clinical reference point for patients at risk for a persistent low subjective well-being.
Methods:
We included 186 patients and 126 healthy control subjects from the Dutch Genetic Risk and Risk and Outcome of Psychosis cohort. SWB was measured with the Subjective Well-being under Neuroleptics-20 (SWN) scale. Assessments took place at baseline, three years and six years follow-up. We used the Five-Factor Inventory to assess neuroticism and extraversion. Positive, negative and depressive symptoms in patients were assessed by the Positive and Negative Symptoms Scale. For controls we used the Community Assessment of Psychic Experiences for investigating subclinical symptoms. By using linear mixed model analyses we investigated the relation between SWB and the personality traits, including the moderating associations of positive, negative, depressive symptoms and a range of psychosocial indicators (among which antipsychotic use and smoking cannabis). An exploratory analysis in the patient sample, investigated the predictive values of personality traits and symptoms at baseline on the course of SWB over 3 and 6 years. Patients were accounted to one of three SWB-trajectories 'stable low', 'low start and improving' and 'stable high'. Results: Mixed model analyses revealed that in patients, high scores of neuroticism and low scores of extraversion were associated with lower SWN-scores: at 3 years: t = -3.07 and t = 4.34 for p < 0.05 and at 6 years: t = -2.62, p = 0.009 and t = 3.51, p = 0.001. We found no interaction effect of time and personality traits. Neuroticism and extraversion were related to SWB to the same extent in the control group. Regarding trajectories over time, we found a stable low SWB in 15.1% of the patients, forming the 'stable low' trajectory group. This group scored highest on neuroticism and lowest on extraversion compared to patients with an increase in SWB or a stable high SWB: neuroticism scores showed post hoc compared mean differences (MD) of 4.25, p = 0.03 for the 'low start increasing'-group and MD 10.75, p <0.001 for the 'stable high'-group). Discussion: We found an association between personality traits and subjective well-being regardless of (subclinical) psychotic or depressive symptoms. Extraversion can be regarded as a resilience factor, whereas neuroticism is associated with a persistent low well-being. In patient with a schizophrenia spectrum disorder, neuroticism could be a focus for therapeutic interventions that diminish negative affectivity. Additionally, an assessment of neuroticism and extraversion early in the process of treatment could be considered. Education and employment status was estimated using longitudinal logistic models utilizing generalized estimating equations with an autoregressive covariance structure to account for within-subject correlations over time. To test how education/employment changed over time, pre-specified contrasts were tested from the longitudinal model for the mean change in sequential follow-up visits. A Kaplan-Meier estimator with discrete time to event and censoring at last observed follow-up month with no event was used to estimate the probability of any education/employment by one year after admission and to estimate the risk of disability by two years after admission.
O11.4. EDUCATION, EMPLOYMENT AND
Results: Approximately 40% of individuals with early psychosis were engaged in school or work upon enrollment in a CSC program; engagement increased to 80% after 6 months of care. The estimated probability of being employed or in school at some time during the year after admission was 87.9% (95% Confidence Interval (CI)= [82.9, 92.0]). Relative to women, men had significantly lower odds of education/employment. Relative to non-Hispanic whites, individuals who were Asian, Hispanic or Black had lower odds of education/ employment. Relative to individuals who had not yet completed high school, individuals whose highest educational attainment was High School (HS) or GED had lower odds of educational/ employment. At admission, 2.5% (17/679) clients were receiving SSA disability benefits. The Kaplan-Meier estimates that 18.3% (95% CI= [13.9, 23.9]) of clients followed for two years obtained disability benefits. In bivariate cox regression analyses, individuals with lower (worse) occupational and social functioning scores have significantly greater risk of disability enrollment than individuals with higher scores (in multivariate analysis, only lower occupational functioning remains significant). Age, gender, race, ethnicity, and symptom scores were not significantly associated with disability enrollment. Discussion: This study demonstrates that individuals with early psychosis who receive CSC in non-research community settings achieve significant improvements in education and employment. Gender, race/ethnicity, and baseline education predicted education and employment outcomes, while poorer functioning was associated with risk of SSA disability benefits. CSC teams should make particular efforts to support the work and school goals of individuals who may be more likely to struggle in achieving engagement in work and school.
